An Important Check-Up On CytomX Therapeutics Inc (NASDAQ: CTMX)
CytomX Therapeutics Inc (CTMX) concluded trading on Wednesday at a closing price of $2.40, with 5.24 million shares of worth about $12.56 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 176.98% during that period and on Wednesday the price saw a gain of […]
CytomX Therapeutics Inc (NASDAQ: CTMX) Has Another Chance To Impress You
Currently, there are 157.54M common shares owned by the public and among those 153.67M shares have been available to trade. The company’s stock has a 5-day price change of -17.60% and 157.24% over the past three months. CTMX shares are trading 100.00% year to date (YTD), with the 12-month market performance up to 3.00% higher. […]
CytomX Therapeutics Inc (CTMX) Volatility Spurs A Quest For Clarity
Currently, there are 80.10M common shares owned by the public and among those 78.64M shares have been available to trade. The company’s stock has a 5-day price change of 121.60% and 169.55% over the past three months. CTMX shares are trading 106.80% year to date (YTD), with the 12-month market performance down to -49.16% lower. […]
Look For Institutional Buying In CytomX Therapeutics Inc (NASDAQ: CTMX)
CytomX Therapeutics Inc (CTMX) concluded trading on Thursday at a closing price of $1.09, with 5.65 million shares of worth about $6.16 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 7.92% during that period and on May 08, 2025 the price saw a […]